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Relevance of oxidative and carbonyl stress to long-term uremic to reduced albumin (mercaptalbumin) [3], increased se-
complications. Oxidative stress is a disturbance of balance be- rum levels of lipid peroxidation products [4, 5], glycoxi-
tween oxidants and antioxidant species. The existence of an dation products [6, 7], “advanced oxidation protein prod-increased oxidative stress in chronic renal failure is supported
ucts” (AOPPs) [8], and protein carbonyls taken as markersby evidence of increased lipid, carbohydrate, and protein oxida-
of protein oxidation [9, 10]. Serum activity of GSH-depen-tion products in plasma and cell membrane. Recent studies
have implicated the oxidative stress in the nonenzymatic bio- dent enzymes is lowered in hemodialysis patients [11, 12].
chemistry leading to irreversible protein modifications. Reac- Dialyzable oxidants measured by electron spin resonance
tive oxygen species may directly alter proteins with the eventual spectroscopy accumulate in uremic plasma [13].formation of oxidized amino acids. Alternatively, reactive car-
The mechanism of uremia-associated oxidative stressbonyl compounds formed by the oxidation of carbohydrates
and lipids may indirectly lead to advanced glycation or lipoxida- is not completely understood. Activation of neutrophils
tion of proteins. Chronic uremia is associated with increased and complement pathway during hemodialysis with an
modification of protein caused by reactive carbonyl compounds attendant enhanced reactive oxygen species production
derived from both carbohydrates and lipids. Increased carbonyl
may contribute to oxidative stress [14]. However, themodification of proteins subsequently results in the rise of
levels of oxidation products in plasma and cell membraneplasma and tissue contents of advanced glycation end products
and advanced lipoxidation end products, in which the deleteri- are elevated even in patients with renal failure prior to
ous biological effects have been revealed. This article focuses the initiation of dialysis therapy. Oxidative stress thus
on the irreversible nonenzymatic modification of proteins, which may result from uremia per se. Plausible explanationsmight, at least in part, contribute to the development of compli-
are impaired renal synthesis of antioxidant enzyme (forcations associated with chronic renal failure and long-term dial-
example, GSH peroxidase) [15], iron supplementationysis, such as atherosclerosis and dialysis-related amyloidosis.
[16], and restriction of food intake, resulting in the deple-
tion of selenium and GSH [17, 18].
Oxidative stress is a disturbance of balance between Recent studies have implicated the oxidative stress in
oxidants and antioxidant species: The former (superox- the nonenzymatic biochemistry leading to irreversible
ide anion radical, hydroxy radical, lipid peroxide radical, protein modifications. Reactive oxygen species may di-
etc.) predominates over the latter consisting of antioxi- rectly alter proteins with the eventual formation of oxi-
dant enzymes [for example, superoxide dismutase, cata- dized amino acids, such as ortho-tyrosine and methionine
lase, glutathione (GSH) peroxidase, GSH-S-transferase], sulfoxide [19]. Alternatively, reactive carbonyl com-
thiols (for example, GSH, cysteine, albumin, and other pounds (RCOs) formed by the oxidation of carbohydrates
protein thiols), urate, ubiquinol, tocopherol, ascorbate, and lipids may indirectly lead to advanced glycation or
carotenoids, etc. lipoxidation of proteins [20]. Chronic uremia is associ-
The existence of an increased oxidative stress in chronic ated with increased modification of protein due to RCOs
renal failure is supported by evidence of increased lipid, derived from both carbohydrates and lipids. Increased
carbohydrate, and protein oxidation products in plasma carbonyl modification of proteins subsequently results
and cell membrane, including increased serum ratios of in the rise of plasma and tissue contents of advanced
oxidized to total ascorbate [1], oxidized to reduced GSH glycation end products (AGEs) and advanced lipoxida-
[2], and oxidized serum albumin (nonmercaptalbumin) tion end products (ALEs), whose deleterious biological
effects have been revealed [20]. This article focuses on
the irreversible nonenzymatic modification of proteins,Key words: oxidative stress, hemodialysis, lipoxidation, glycation, ath-
erosclerosis, amyloidosis. which might, at least in part, contribute to the develop-
ment of complications associated with chronic renal fail-Ó 2000 by the International Society of Nephrology
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ure and long-term dialysis, such as atherosclerosis and dialysis patients are not correlated with the levels of
fluctoselysine, an Amadori product used as a markerdialysis-related amyloidosis.
of prevailing plasma glucose concentration. This is in
contrast with the observation that in diabetic patients,
ACCUMULATION OF RCOs AND AGEs/ALEs IN
tissue and serum levels of AGEs are correlated with
UREMIA (CARBONYL STRESS)
fructoselysine [33, 34]. Similarly, the levels of malondial-
Carbohydrates, lipids, and amino acids, abundantly dehydelysine present in uremic serum are not correlated
present in human body, are the precursors for RCOs. with triglycerides. These findings suggest that a factor(s)
Carbohydrates and ascorbate may generate RCOs, for other than hyperglycemia and hyperlipidemia determines
example, glyoxal, methylglyoxal, arabinose, glycoalde- the rate of AGE and ALE formation in renal failure.
hyde, 3-deoxyglucosone, and dehydroascorbate [21–25]. Over 90% of the pentosidine and CML measured in
The RCOs react nonenzymatically with protein amino uremic plasma was found in the albumin fraction [5, 6].
groups and form reversible Schiff-base adducts trans- Their accumulation is thus not due to a decreased renal
formed subsequently into more stable, slowly reversible clearance of protein-linked AGEs or ALEs. It has there-
Amadori rearrangement products. Through a series of fore been hypothesized that the accumulation in uremia
oxidative and nonoxidative reactions, they eventually of AGEs/ALEs is the consequence of raised levels of
form irreversibly AGEs, for example, carboxymethylly- RCOs derived from carbohydrates and lipids.
sine (CML), pentosidine, pyrraline, imidazolone, gly- Pentosidine generation in plasma samples incubated
oxal-lysine dimmer (GOLD), and methylglyoxal-lysine under air for several weeks is markedly higher in uremic
dimmer (MOLD) [20]. than normal plasma. This difference is still observed
Lipid peroxidation of polyunsaturated fatty acids such when plasma ultrafiltrates (5000 D filter cutoff) are incu-
as arachidonate also generates RCOs [26, 27], for exam- bated with normal human serum albumin. The pentosi-
ple, glyoxal, malondialdehyde, hydroxynonenal, and acro- dine yield in the ultrafiltrate is significantly higher in
lein. These highly reactive RCOs combine with proteins predialysis than in postdialysis plasma samples. Inhibi-
and form ALEs, for example, malondialdehyde-lysine, tors of carbonyl amine reaction with proteins, aminogua-
hydroxynonenal, and acrolein-protein adduct, as well as nidine and OPB-9195, significantly reduce the produc-
AGEs, for example, CML, but not pentosidine [20]. Fi- tion of pentosidine in both control and uremic plasma
nally, RCOs are also generated during the myeloper- [31]. These results support the concept that uremia is
oxidase-catalyzed metabolism of amino acids, l-serine, characterized by increased levels of low molecular levels
and l-threonine, for example, glyoxal, methylglyoxal, of RCOs, precursors of pentosidine. Of interest, there
acrolein, and glycoaldehyde [28]. is a clear correlation between pentosidine levels mea-
In chronic uremia, the levels of RCOs derived from sured in plasma and that generated in vitro after incuba-
a variety of sources are markedly increased in the plasma. tion under air for several weeks [31]. If the in vitro
Raised levels of glyoxal [29], methylglyoxal [29], 3-deox- pentosidine generation is determined by the initial RCO
yglucosone [30], dehydroascorbate [1], and malondialde- contents of plasma, this observation suggests that the
hyde [5] have been demonstrated in the plasma of hemo- plasma pentosidine level is an appropriate surrogate
dialysis patients. Total RCOs have also been assessed marker of the level of pentosidine precursor RCOs. The
by the reaction of 2,4-dinitrophenydrazine with plasma: accumulation of various RCOs derived from carbohy-
The yield of hydrazone formed by interaction with car- drates and lipids in uremia and the subsequent carbonyl
bonyl groups is several times higher in uremic than in modification of protein are called “carbonyl stress” [20].
normal plasma [31]. Under carbonyl stress, not only AGEs derived from car-
The resulting levels of AGEs and ALEs are also raised bohydrates but also ALEs derived from lipids accumu-
in uremia. Pentosidine [6], determined by high-perfor- late in plasma and probably in tissue proteins as well.
mance liquid chromatography (HPLC), and CML [5],
determined by gas chromatography/mass spectrometry,
MECHANISM OF CARBONYL STRESS:are significantly higher in plasma and tissue proteins of
OXIDATIVE STRESS?hemodialysis patients than in normal or diabetic subjects.
Other AGEs, such as GOLD and MOLD, also accumu- The carbonyl stress of uremia is not completely under-
stood. Two mechanisms should be considered. First, itlate in uremic plasma [32]. The levels of malondialdehyde-
lysine, taken as a surrogate marker for ALEs, are also may result from an increased generation of RCOs under
oxidative stress. Under oxidative stress, the carbohy-raised in the plasma proteins of hemodialysis patients
[5]. Uremia is thus characterized by the irreversible, non- drates and lipids are modified by reactive free radicals.
The autoxidation of carbohydrates yields glyoxal, arabi-enzymatic modification of proteins by RCOs derived
from carbohydrates and lipids, that is, AGEs/ALEs. nose, and glycoaldehyde and that of ascorbate, dehy-
droascorbate [22, 23, 25]. As described previously in thisPlasma levels of pentosidine [6] and CML [5] in hemo-
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article, lipid peroxidation and oxidation of l-serine and of reactive free radicals generated in uremia (oxidative
stress). Alternatively, it might be derived from nonoxida-l-threonine yield glyoxal malondialdehyde, hydroxyno-
nenal, acrolein, and glycoaldehyde [26–28]. tive mechanism(s) as demonstrated in diabetes. Under
these circumstances, the polyol pathway is activated byThe relationship between oxidative stress and car-
bonyl stress is further supported by the reports that se- hyperglycemia and consumes NADPH for the reduction
of glucose to sorbitol, a process catalized by aldose reduc-rum levels of pentosidine are correlated with oxidative
markers such as dehydroascorbate [1] and AOPP [8]. tase [40]. NADPH is thus less available for GSH reduc-
tase so that GSH levels fall.It should be pointed out, however, that RCOs derived
from nonoxidative chemistry also rise simultaneously in Interestingly, the decreased thiol concentration alters
the antioxidant systems and may mimic an oxidativeuremic plasma without concomitant changes in glucose
or lipid levels. 3-Deoxyglucosone and methylglyoxal are stress. In the absence of oxidative stress, the decreased
thiol concentration increases the ratios of oxidized toformed nonoxidatively by the decomposition of the
Amadori product fructose-3-phosphate and of triose total ascorbate, of oxidized to reduced GSH, and of
nonmercaptalbumin to mercaptalbumin as well as thephosphates, respectively [18, 20]. Their plasma levels as
well as that of their protein adducts are increased in the levels of lipid peroxidation products and of glycoxidation
products on protein in the serum. The serum activity ofplasma of hemodialysis patients [29, 30, 32].
The second hypothesis for the uremic carbonyl stress GSH-dependent enzymes also decreases. Thus, the lines
of evidence taken to indicate a uremia-associated oxida-rests on a decreased clearance or detoxification of RCOs.
RCOs derived from both oxidative and nonoxidative tive stress may be interpreted differently. The existence
of an oxidative stress in diabetes has also been controver-chemistry of both carbohydrates and lipids have a rather
low molecular weight so that their removal might rely sial. Recently, however, Wells-Knecht et al have demon-
strated that age-adjusted levels of ortho-tyrosine andon renal function in uremic and diabetic patients. [35, 36].
In addition to renal removal, a number of enzymatic methionine sulfoxide, markers of oxidative protein dam-
pathways contribute to the detoxification of RCOs, for age, are not increased in the skin collagen of diabetic
example, aldose reductases, aldehyde dehydrogenases, patients, and they postulated that there is no need to
and the glyoxalase pathway [22]. A decrease in their invoke an increase in oxidative stress in diabetes [41].
efficiency can readily result in the simultaneous increase It therefore remains of particular interest to establish
of a wide range of RCOs. Redox coenzymes, reduced whether chronic renal failure is associated with oxidative
GSH, and nicotinamide adenine dinucleotide phosphate stress. Measurements of ortho-tyrosine and methionine
[NAD(P)H] are particularly important elements for the sulfoxide in tissue proteins from uremic patients should
activity of these pathways. RCOs, such as methylglyoxal provide critical evidence in this regard. A precise answer
and glyoxal react reversibly with thiol group of GSH would also indicate whether the decreased thiol concen-
to be subsequently detoxified by glyoxalase. NAD(P)H tration in uremia is due to an oxidative stress or to an-
increases the activity of GSH reductase and replenishes other nonoxidative mechanism. Whatever the answer to
GSH. Alteration of GSH homeostasis may impair the these questions, it remains clear that uremia is character-
detoxification of RCOs and may increase the AGE/ALE ized by AGE and ALE modification of proteins due
genesis. to the accumulation of carbohydrate and lipid-derived
The GSH concentration in red blood cells and serum reactive carbonyl species.
activity of GSH-dependent enzymes of uremic patients
are indeed significantly lower than in normal subjects [2,
IMPLICATIONS OF CARBONYL STRESS11, 12]. Increased RCOs levels might be the consequence
Several lines of evidence have suggested links betweenof a decrease of thiol storage in uremia, for example,
carbonyl stress and the development of complicationsGSH, NADPH, and mercaptoalbumin. This hypothesis
associated with chronic renal failure and long-term dial-is supported by our recent observation that the addition
ysis. Dialysis-related amyloidosis is a serious bone andof GSH in both uremic and normal plasma lowers the
joint destruction associated with chronic renal failure.generation of pentosidine after incubation in vitro (un-
It develops in two stages [42]. The preclinical stage ispublished) and that GSH peroxidase activities correlate
characterized by histologic evidence of b2-microglobulininversely with the pentosidine levels in the plasma of
deposits in the joints several years before the onset ofhemodialysis patients [12]. Similarly, several other groups
clinical or radiological signs [43]. Amyloid fibrils precipi-have suggested that decreased GSH peroxidase activities
tate in the absence of macrophages or bone destruction.increase the generation of hydrogen peroxide, which fur-
The subsequent clinical stage is characterized by arthral-ther accelerates the formation of AGEs/ALEs [37–39].
gias, carpal tunnel syndrome, and radiologically visibleThe decreased thiol concentration in uremia is as yet
bone cysts. Amyloid deposits are surrounded by macro-not fully understood. It might result from an increased
consumption in order to detoxify an augmented load phages and bone resorption. Recent immunohistochemi-
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Table 1. Biological effects of AGEs/ALEs and RCOs sponse element [59]. Recently, it has been demonstrated
that RCOs forming Schiff base with lysine residues ofReferences
the calcitriol receptor inhibit its interaction with vitamin DAGEs/ALEs Chemotaxis of monocytes [52, 53]
Inflammatory cytokine secretion from macrophages response element [60]. RCOs are also biologically active
[52, 54] and initiate a variety of cellular responses [61]. Exposure
Collagenase secretion from synovial cells [52]
of cultured rat or human mesothelial or endothelial cellsOsteoclast-induced bone resorption [55]
Proliferation of vascular smooth muscle cells [56] to methylglyoxal increased mRNA and protein synthesis
Aggregation of platelets [57] of vascular endothelial growth factor (VEGF) [62].
Intracellular signaling [63]
Finally, intracellular signaling pathways of carbonylRCOs Structural alteration of matrix proteins
Resistance to the action of calcitriol stress have been elucidated. First, AGEs, upon interaction
VEGF production from endothelial and mesothelial with the receptor for AGEs, trigger the signaling involv-
cells [62]
ing P21ras, mitogen-activated protein kinases (MAPKs),Cell apoptosis [65, 66]
Intracellular signaling [61, 64, 65] and nuclear factor-kB [63]. Second, exposure of murine
thymocytes or fibroblasts to glyoxal, a glucose-derived
RCO, activates protein kinases such as c-Src and in-
creases intracellular tyrosine phosphorylation of several
cal and chemical analyses indicate that b2-microglobulin cellular proteins [64]. Formation of carbonyl-induced
amyloid deposits are modified by carbonyl stress. The Schiff base with cell surface protein is crucial for genera-
amyloid plaques react with anti-AGE (CML, pentosidine, tion of the signal, because a potent Schiff base inhibitor,
and imidazolone) anti-ALE (malondialdehyde-lysine OPB-9195, inhibits the intracellular protein-tyrosine phos-
and hydroxynonenal-protein adduct) as well as with anti- phorylation induced by glyoxal [64]. Third, hydroxy-
receptor for AGE (RAGE) antibodies [44–48]. nonenal, a lipid derived RCO, caps epidermal growth
Atherosclerosis is also a long-term complication of factor receptor (EGFR), a receptor tyrosine kinase, on
uremia. AGEs levels in arterial tissues are higher in dial- the cell surface in A431 cells, mimics EGF, and induces
ysis patients than in normal subjects [49]. Immunohisto-
the downstream signaling pathways involving MAPKs,chemical examination reveals the presence of AGEs/
known to play a role in oxidative stress-linked–inducedALEs in the thickened neointima [50]. It should be rec-
apoptotic cell death [65]. Finally, hydroxynonenal alsoognized that the formation of AGEs/ALEs in vascular
triggers oxidative stress-linked-induced apoptotic celllesions is not specific to uremia, but might be common
death by activating caspase-3 through a Fas-independentto most, if not all, types of vascular damage, irrespective
but GSH-dependent redox pathway [66].of its cause whether metabolic or mechanical. AGEs/
ALEs are thus identified in vascular lesions of aged sub-
jects, of diabetic patients [51], and after balloon injury CONCLUSIONS
of the carotid artery [50]. Despite several lines of evidence, the presence of an
Whether AGEs/ALEs are active elements in the patho- oxidative stress in renal failure remains to be conclu-
genesis of these disorders or only innocent, passive by-
sively established. Nevertheless, chronic renal failure isstanders remains to be demonstrated. Several lines of
a state of carbonyl stress, that is, accumulation of RCOsevidence favor the former view. First, AGE/ALE-modi-
from a variety of sources and the resultant increasedfied proteins, which are prepared in vitro by incubation
carbonyl modification of proteins leading to AGE/ALEwith glucose for several months, exhibit several biologi-
formation. This carbonyl stress may result either fromcal activities (Table 1). They initiate a range of inflam-
oxidative stress or from other nonoxidative causes, formatory responses, including stimulation of monocyte
example, depletion of thiols. Whatever its cause, thechemotaxis [52, 53], secretion of inflammatory cytokines
carbonyl stress alters the structure and function of cellu-from macrophages [52–54], stimulation of collagenase
lar and matrix proteins and may contribute to the devel-secretion from synovial cells [52], stimulation of osteo-
opment of uremia-associated complications.clast-induced bone resorption [55], proliferation of vas-
cular smooth muscle cells [56], and stimulation of aggre-
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P, Menini C, Gammaro L, Corrocher R: Low platelet glutathioneAPPENDIX
peroxidase activity and serum selenium concentration in patients
with chronic renal failure: Relationship between dialysis treatments,Abbreviations used in this article are: AGE, advanced glycation end
product; ALE, advanced lipoxidation end product; AOPP, advanced diet and cardiovascular complications. Clin Sci 84:611–617, 1993
18. Hasselwander O, Young IS: Oxidative stress in chronic renaloxidation protein product; CML, carboxymethyllysine; EGFR, epider-
mal growth factor receptor; GOLD, glyoxal-lysine dimmer; GSH, glu- failure. Free Radic Res 29:1–11, 1998
19. Stadtman ER, Oliver CN: Metal catalyzed oxidation of proteins:tathione; MAPK, mitogen activated protein kinase; MOLD, methylgly-
oxal-lysine dimmer; NAD(P)H, nicotinamide adenine dinucleotide Physiological consequences. J Biol Chem 266:2005–2008, 1991
20. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes(phosphate); RCO, reactive carbonyl compound; VEGF, vascular en-
dothelial growth factor. JW: Alterations in non-enzymatic biochemistry in uremia: Origin
and significance of “carbonyl stress” in long-term uremic complica-
tions. Kidney Int 55:389–399, 1999
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